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High expression levels of recombinant proteins do not 
necessarily mean that the protein must be in inclusion 
bodies (IBs). This talk will describe some of the more 
successful solutions to the problem of expressing 
proteins in an active form in E. coli. 
Many groups prefer to express proteins in an insoluble 
form, primarily because of the advantages listed in 
Table 1. The disadvantages are often ignored. 
Advantaqes of IBs Disadvantaqes 
High expression level> Refolding shifts problems and 
reduced fermentation costs costs downstream. 
Production can be monitored Production cannot be monitored 
with PAGE or immunoblottina directly bv activity. 
Cytoplasmic proteins are washed The other "5%" contaminants are 
away, simplifying purification. hydrophobic, poorly soluble 
"95%" purity can be quickly membrane proteins and cell 
achieved wall fraoments 
The major contaminants are Separation of multiple forms of 
oligomers and misfolded or the same protein is the most 
proteolyzed forms of the difficult purification step. 
desired protein 
The pL promotor with T If the protein does not refold 
induction often yields protein well, another expression system 
where other systems fail will still be needed. 
When to use inclusioo bodies' The most successful IB 
purification schemes have been for small flexible 
proteins. IB purifications are often favoured by 
university labs with no access to fermentors, as large 
amounts of protein can be produced in shaker flask 
culture. Increasing cell density per liter does not 
improve economics, as the limiting factor in the 
purification is the volume required for refolding. IBs 
are also useful for the production of factors toxic for 
bacteria that are not producible by secretion (eg., 
histones). In addition, no successful system for 
producing membrane proteins in a soluble form has been 
described. 
The difficulties of refolding larger proteins 
economically have proved prohibitive. Animal cell 
cultivation was more economical for production of tPA 
than production in IBs because the purification costs 
were so high (Datar, Cartwright, & Rosen, MS in prep.). 
Integration of upstream and dowstream processing The 
choice of protein expression system should not be left 
to the fermentation group. Their emphasis is usually on 
rapid and cheap production of large amounts of protein, 
with little regard to the downstream purification. It 
is important to keep all options open at the beginning 
of the cloning, because once a process is running, it is 
hard to change anything. Although protein purification 
is complex, it should be thought of as a stream that 
starts at the fermentor and ends in vials of purified 
product. 
The only valid yield figure for a process is the amount 
of usable protein produced per liter of culture fluid. 
As simple as this definition sounds, real yield figures 
tend to be elusive. Several groups, often in different 
cities, take part in the purification. True costs per 
mg protein are also difficult to calculate at the lab 
scale as labor costs are often underestimated. 
Secretioo systems In some cases, the desired protein 
is too toxic or sensitive to proteolysis to be expressed 
intracellularly in a soluble form. Secretion from E. 
coli has been very successful for heterologous proteins 
that are secreted in their original environment, 
including human growth hormone,1 "humanized" antibodies,2 
and bacterial3 and mammalian4 RNases. Secretion from 
other bacterial species, yeasts, and fungi is also 
possible. 
Yields in secretion systems can be increased by growing 
the cells to high densities and by using host strains 
s~lected for low protease production. Optimizing the 
growth temperature, reducing air bubbling and adding 
protease inhibitors or detergents to the medium can also 
help to increase protein in the supernatant. 
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Expressing soluble proteins intracellularly.One of the 
easiest and most generally applicable method to increase 
the protein in the soluble fraction is to reduce the E. 
coli growth temperature. 5 Table 2 lists a few proteins 
that are more soluble when produced in E.coli grown at 
30°C or less. 
Protein' 
HAmmi'Jian' 
human Interferon-a2 
human Interferon-y 
murine Mx 
human Interferon-~ 
human transforming 
growth factor-~ 
rabbit muscle glycogen 
phosphorylase 
murine cAMP-dependent 
protein kinase 
(catalytic subunit) 
UAJlt..;. 
radish 3-0H-3-methyl 
glutary1coenzyme A 
reductase 
rice lipoxygenase L-2 
yeast a-glucosidase Pl 
BActeria' 
T4 DNA polymerase 
Ricin A-chain 
Diphtheria toxin & fusion 
proteins 
P22 tails pike 
Subtilisin E (secretion 
system) 
Promotor' 
T7, colEl, 
Amp 
pTrp 
pTrp 
pTrp 
pTrp 
pTrp1ac 
hybrid, T7 
T7 
T7 
T7 
tac-hybrid 
Reference' 
Reference 5 
Mizukami,et al. (1986 ) 
Biotech. Letters 8,605 
Seow, et al. (1989) Gene 
83,117-129. 
Browner,et al. (1991) 
Prot. Eng. 4:351 
Slice, L.W. & Taylor, 
5.5. (1989) J. Biol. 
Chern. 264,20940 
Ferrer et al. (1990) 
FEBS Let. 266,67-71. 
Shirano,Y.& Shibata,D. 
(1990) FEBS Let271,128 
Kopetzki,et a1. (1989) 
Mol. Gen. 
Genet. 216, 149 
pL, ptac Lin,et a1. (1987) Proc. 
Natl. Acad.Sci.84,7000 
pL,pTrp, Piatak,et al. (1988) 
1acUV5 J.Biol. Chern. 263, 
4837,Ready et 
a1. (1991) Prot. Struc. 
Func. Gen. 10, 270 
trc Bishai et al. (1987) J. 
Bacteriol. 169, 5140 
phage Haase-Pettingell, C.A. 
promotor and King, J. (1988) J. 
BioI. Chern. 263, 4977 
tandem Takagi,et al. (1988) 
1pp/1ac-OrnoA Bio/Techno1oqv 6 948 
Changes in the protein sequence. In some cases, one 
might consider altering the protein sequence to obtain a 
protein with better solubility characteristics. For 
example, discrete changes in human hemoglobin make a 
more stable protein for use in blood substitutes, and 
the solubility of insulin preparations can be altered by 
changing residues at the oligomer interface. The in 
vivo and in vitro aggregation tendencies of a protein 
do not necessarily correlate. 
Certain proteins remain soluble under all growth 
conditions. Several examples of a single amino acid 
change rendering a protein more 6 or less7 likely to form 
IBs have been found. 
In conclusion, there are now many ways to express large 
amounts of protein in a soluble form in E. coli. We can 
for the most part control the solubility of proteins 
produced, so we no longer need to live with IBs unless 
we want to. 
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